ON Helix: Translating UK Scientific Excellence into Global Therapeutic Strategies

Engineered Human Therapies
by
|
May 14, 2016

ON Helix is a one day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).Date: 28 June 2016Location: Wellcome Genome Campus, Hinxton, Cambridge

ON Helix is our translational research conference for the life science sector.

It will present the UK landscape of the business environment, funding, scientific and clinical research excellence and will be a unique knowledge-sharing environment between academia and business:

  • The Future of Medicines: Do Patients Make the Best Models?
  • The Role of Technology Transfer Offices
  • Funding Early Stages of Translational Medicine

We are delighted to announce our:Keynote Speakers:Dr Susan Windham-Bannister, Former President and CEO of the Massachusetts Life Sciences CenterDr David Roblin, Chief Operating Officer and Director of Translation at The Francis Crick InstituteProfessor Nick Lemoine, Medical Director at the NIHR and Director of Barts Cancer InstituteProfessor Sir John Savill, CEO of the Medical Research Council will also be delivering keynote addressesand our VIP Guest of Honour who will be starting the day off.Click to view our 2016 programme for ON Helix.The conference will commence with a Welcome Reception and BioNewsRound Awards on 27 June, more information can be found here.To register, please click here. Delegate RatesMembership StatusDelegate RateExhibition standsOne Nucleus Gold Member£145£850One Nucleus Silver Member£275£950One Nucleus Non-Member£425£1150Academic**£145-For further details visit our dedicated website www.onhelix.com Follow us on Twitter @OneNucleus using #onhelix16

Related Articles

No items found.

ON Helix: Translating UK Scientific Excellence into Global Therapeutic Strategies

by
May 14, 2016

ON Helix: Translating UK Scientific Excellence into Global Therapeutic Strategies

by
May 14, 2016

ON Helix is a one day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).Date: 28 June 2016Location: Wellcome Genome Campus, Hinxton, Cambridge

ON Helix is our translational research conference for the life science sector.

It will present the UK landscape of the business environment, funding, scientific and clinical research excellence and will be a unique knowledge-sharing environment between academia and business:

  • The Future of Medicines: Do Patients Make the Best Models?
  • The Role of Technology Transfer Offices
  • Funding Early Stages of Translational Medicine

We are delighted to announce our:Keynote Speakers:Dr Susan Windham-Bannister, Former President and CEO of the Massachusetts Life Sciences CenterDr David Roblin, Chief Operating Officer and Director of Translation at The Francis Crick InstituteProfessor Nick Lemoine, Medical Director at the NIHR and Director of Barts Cancer InstituteProfessor Sir John Savill, CEO of the Medical Research Council will also be delivering keynote addressesand our VIP Guest of Honour who will be starting the day off.Click to view our 2016 programme for ON Helix.The conference will commence with a Welcome Reception and BioNewsRound Awards on 27 June, more information can be found here.To register, please click here. Delegate RatesMembership StatusDelegate RateExhibition standsOne Nucleus Gold Member£145£850One Nucleus Silver Member£275£950One Nucleus Non-Member£425£1150Academic**£145-For further details visit our dedicated website www.onhelix.com Follow us on Twitter @OneNucleus using #onhelix16

RECENT INDUSTRY NEWS
RECENT INSIGHTS
Sign Up Now